Noxopharm aims for autoimmune market with first human trial of SOF-SKN
Biotech company Noxopharm Ltd (ASX:NOX) has announced that the first human trial…
Noxopharm Limited (ASX:NOX)
About Noxopharm Limited
Key Information
NOX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 18/12/2024 | Convertible Note update | 181.31KB | 175 |
| 16/12/2024 | Change of Director's Interest Notice - BP | 4.67KB | 200 |
| 16/12/2024 | Notification of cessation of securities - NOX | 12.65KB | 136 |
| 04/12/2024 | Contract Research Organisation signed for HERACLES trial | 192KB | 297 |
| 19/11/2024 | Results of Meeting | 201.09KB | 358 |
| 19/11/2024 | Noxopharm 2024 AGM Corporate Presentation | 2.45MB | 377 |
| 19/11/2024 | Noxopharm 2024 AGM Chair Address | 206.28KB | 244 |
| 12/11/2024 | Noxopharm enhances 2024 cash position via R&D rebate | 195.66KB | 377 |